Find Research outputs — UTMB Health Research Expert Profiles

2019

Identification and evaluation of antivirals for Rift Valley fever virus

Lang, Y., Li, Y., Jasperson, D., Henningson, J., Lee, J., Ma, J., Li, Y., Duff, M., Liu, H., Bai, D., McVey, S., Richt, J. A., Ikegami, T., Wilson, W. C. & Ma, W., Mar 2019, In: Veterinary Microbiology. 230, p. 110-116 7 p.

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

2015

Rift Valley fever virus MP-12 vaccine is fully attenuated by a combination of partial attenuations in the S, M, and L segments

Ikegami, T., Hill, T. E., Smith, J. K., Zhang, L., Juelich, T. L., Gong, B., Slack, O. A. L., Ly, H. J., Lokugamage, N. & Freiberg, A. N., 2015, In: Journal of virology. 89, 14, p. 7262-7276 15 p.

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

2016

Optimized P2A for reporter gene insertion into nipah virus results in efficient ribosomal skipping and wild-type lethality

Park, A., Yun, T., Hill, T. E., Ikegami, T., Juelich, T. L., Smith, J. K., Zhang, L., Freiberg, A. N. & Lee, B., Apr 2016, In: Journal of General Virology. 97, 4, p. 839-843 5 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR

Nishiyama, S., Slack, O. A. L., Lokugamage, N., Hill, T. E., Juelich, T. L., Zhang, L., Smith, J. K., Perez, D., Gong, B., Freiberg, A. N. & Ikegami, T., Nov 16 2016, In: Virulence. 7, 8, p. 871-881 11 p.

Research output: Contribution to journal › Comment/debate › peer-review

11 Scopus citations

2019

Candidate vaccines for human Rift Valley fever

Ikegami, T., Jan 1 2019, (Accepted/In press) In: Expert Opinion on Biological Therapy.

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

2015

MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters

Gowen, B. B., Westover, J. B., Sefing, E. J., Bailey, K. W., Nishiyama, S., Wandersee, L., Scharton, D., Jung, K. H. & Ikegami, T., 2015, In: Frontiers in Microbiology. 6, JUN, 651.

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

2016

Application of droplet digital PCR to validate rift valley fever vaccines

Ly, H. J., Lokugamage, N. & Ikegami, T., Apr 1 2016, Methods in Molecular Biology. Humana Press Inc., Vol. 1403. p. 207-220 14 p. (Methods in Molecular Biology; vol. 1403).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

3 Scopus citations

N-glycans on the rift valley fever virus envelope glycoproteins Gn and Gc redundantly support viral infection via DC-SIGN

Phoenix, I., Nishiyama, S., Lokugamage, N., Hill, T. E., Huante, M. B., Slack, O. A. L., Carpio, V. H., Freiberg, A. N. & Ikegami, T., May 23 2016, In: Viruses. 8, 5

Research output: Contribution to journal › Article › peer-review